TipRanks
Advertisement
Advertisement
Grace Therapeutics initiates dual-source manufacturing strategy for GTx-104
PremiumThe FlyGrace Therapeutics initiates dual-source manufacturing strategy for GTx-104
2M ago
Grace Therapeutics advances dual-source manufacturing for GTx-104
Premium
Company Announcements
Grace Therapeutics advances dual-source manufacturing for GTx-104
2M ago
Grace Therapeutics receives Type A meeting minutes from FDA
Premium
The Fly
Grace Therapeutics receives Type A meeting minutes from FDA
2M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
5M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
5M ago
Grace Therapeutics Updates GTx-104 Regulatory and Trial Progress
Premium
Company Announcements
Grace Therapeutics Updates GTx-104 Regulatory and Trial Progress
5M ago
Grace Therapeutics down 48% after receipt of CRL from FDA for GTx-104
PremiumThe FlyGrace Therapeutics down 48% after receipt of CRL from FDA for GTx-104
6M ago
Grace Therapeutics, Inc trading resumes
Premium
The Fly
Grace Therapeutics, Inc trading resumes
6M ago
Grace Therapeutics issued Complete Response Letter from FDA
Premium
The Fly
Grace Therapeutics issued Complete Response Letter from FDA
6M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―